CircuLite is a company developing a unique circulatory assistance device for the treatment of chronic heart failure. Synergy™, the company’s pocket circulatory assistance device features a micro-pump that is placed superficially and minimally invasively connected to the left atrium and the subclavian artery. Once in place, the device transforms the treatment of chronic heart failure patients, irrespective of whether they are hospitalised or treated as outpatients. The company received CE marking on 5 September 2012 for its Synergy™ device.
Heartware Inc. (Nasdaq: HTW) acquired Circulite in December 2013 for an initial sum of $30 million, potentially rising to $320 million if it hits its milestones.
Heartware Inc. (Nasdaq: HTW) acquired Circulite in December 2013 for an initial sum of $30 million, potentially rising to $320 million if it hits its milestones.
Total raised: $30M
Investors 1
| Date | Name | Website |
| - | Omnes Capi... | omnescapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.11.2011 | Series D | $30M | - |
Mentions in press and media 6
| Date | Title | Description |
| 09.05.2012 | 5 cardiovascular disease medical device companies to watch | “The aging of the population and the near epidemic of obesity and type 2 diabetes even in the younger population will prolong this trend and sustain potential in this market for a long time to come,” said Kenneth Krul, author of a cardiovas... |
| 30.11.2011 | CircuLite Raises $30M Series D | Developer of the world's smallest surgically implanted blood pump for long-term use in heart failure patients, today announced that it has raised a total of $30 million in an oversubscribed Series D financing round. The round was led by a... |
| 30.11.2011 | CircuLite Raises $30M in Series D Funding | CircuLite, Inc., a Saddle Brook, NJ-based developer of innovative solutions to improve the treatment of advanced heart failure, has raised $30min Series D funding. The round was led by new investor MacAndrews & Forbes Holdings Inc., and... |
| 30.11.2011 | CircuLite raises $30M for world’s smallest blood pump | Funding Roundup | CircuLite Inc. landed $30 million in an oversubscribed Series D financing round led by McAndrews & Forbes Holdings Inc. and Forbion Capital Partners. The Saddle Brook, N.J.-based company will use the funds to support the European commer... |
| 05.01.2010 | CircuLite Completes $32.5M Series C Financing | CircuLite, Inc., a Saddle Brook, NJ-based cardiovascular device company, has closed its $32.5m Series C round of financing. Forbion Capital Partners led the round, and was joined by Crédit Agricole Private Equity, Foundation Medical Partner... |
| - | 5 cardiovascular disease medical device companies to watch | Estimates on the size of the U.S. market for treating cardiovascular disease vary, but few doubt the market is big and getting bigger. Americans afflicted with cardiovascular diseases like cardiomyopathy, congestive heart failure, arrhythmi... |